Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease

COLAK Y., SENATES E., OZTURK O., DOGANAY H. L., Coskunpinar E. M., Oltulu Y. M., ...Daha Fazla

METABOLIC SYNDROME AND RELATED DISORDERS, cilt.10, sa.2, ss.103-109, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 2
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1089/met.2011.0111
  • Dergi Adı: METABOLIC SYNDROME AND RELATED DISORDERS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.103-109
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is one of the most common causes of chronic liver disease, worldwide. Lipoprotein-associated phospholipase A2 (Lp-PLA2) was recently characterized as a novel inflammatory biomarker that is correlated with several components constituting the metabolic syndrome.